ALUROTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ALLURION TECHNOLOGIES, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 15, 2026
$0.47+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.34M
- P/E (TTM)
- –
- Dividend yield
- –
ALLURION TECHNOLOGIES, INC. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Countries | $7.38M | $11.24M | $12.95M | $14.67M | $21.24M | $25.42M | $23.39M | $31.85M | $34.21M | $35.08M | $41.11M | $41.65M | 58.6% | -65.3% |
| Italy | $2.07M | $1.84M | $1.65M | $1.74M | $2.19M | $2.69M | – | – | – | – | – | – | 16.4% | -5.7% |
| Spain | $1.79M | $2.15M | $2.82M | $2.98M | $3.65M | $4.01M | $3.90M | $4.66M | $4.11M | $4.62M | $4.70M | $6.04M | 14.2% | -51.0% |
| United States | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | – | $0 | – | – | 0.0% | – |
| France | – | – | – | – | – | $2.49M | – | $5.99M | $5.39M | $5.57M | $6.16M | $6.00M | – | – |
| TRY | – | – | – | – | – | $1.57M | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Allurion Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.